Event National conference on rare diseases (NAKSE) 28th to 29th of Sept 2023, Berlin, DE Dr. rer. nat. Ingo Hantke Is there really a need for adaptation in the benefit assessment of orphan drugs? more
Event Access Europe 23 2nd to 4th of Oct 2023, Budapest Prof. Matthias P. Schönermark, M.D., Ph.D. Excellence for Market & Patient Access, Pricing and Reimbursement more
Event World Orphan Drug Congress 2023 30th of Oct to 2nd of Nov 2023, Barcelona, ES Dipl.-Kauffrau Heike Kielhorn-Schönermark Strategy, advocacy and partnering for the orphan drug industry more
Event ISPOR Europe 12th to 15th of Nov 2023, Copenhagen, Denmark Prof. Matthias P. Schönermark, M.D., Ph.D. Visit us at our booth C2-043. more
Event Web Summit 2023 13th to 16th of Nov 2023, Lisbon, PT Marius Luding Meet us at the world's largest tech conference. more
Event Advanced Therapies Europe 5th to 7th of Sept 2023, Lisbon, PT Dr. rer. nat. Lydia Frick JCA, pricing and reimbursement opportunities of novel therapeutics in Europe more
Event Digital Health Masterclass 28th of Aug 2023 Hannover Prof. Matthias P. Schönermark, M.D., Ph.D. How to DiGA and DiPA more
Event How do we get ATMPs over the line in Europe? 8th of June 2023 Online Prof. Matthias P. Schönermark, M.D., Ph.D. Webinar: Ready for market more
Event Development of Orphan Biologics: Challenges and Opportunities 18th of Apr 2023 Online Prof. Matthias P. Schönermark, M.D., Ph.D. Webinar on orphan drugs more
Event World Evidence, Pricing and Access Congress 21st to 23rd of Mar 2023, Amsterdam, NL Dipl.-Kauffrau Heike Kielhorn-Schönermark Market Access & Pricing, Rare Diseases and ATMPs more
Event Meetup #2 Digital Health City Hannover 15th of Mar 2023 Hannover Prof. Matthias P. Schönermark, M.D., Ph.D. What is digital health capable of? more
Event Advanced Therapies Congress 2023 14th to 15th of Mar 2023, London, UK Dr. rer. nat. Lydia Frick Research - Develop - Collaborate - Commercialise more
Event DGGÖ annual conference 2023 13th to 14th of Mar 2023, Hannover Ina Berger Gaps between theoretical assessment, practical benefit and reimbursement of gene therapies more
